Atomoxetine
Cognitive · Selective NRI
Tier B
Bottom line
Read Off Label grades Atomoxetine as B (6.4/10) based on strong evidence, med benefit magnitude, and a med-risk safety profile.
Full effect takes 4-8 weeks.
Studied, labeled, or reported-use context: 40-100 mg PO daily — Rx; not individualized guidance.
What the evidence says
Full effect takes 4-8 weeks. Moderate effect size in ADHD — smaller than stimulants on average. It is used when stimulants are contraindicated or when anxiety or substance-use risk affects treatment selection. Not a DEA-scheduled drug.
Mechanism
Selective norepinephrine reuptake inhibitor; also increases PFC dopamine (NET clears DA in frontal cortex); non-stimulant; no abuse potential
Studied, labeled, or reported dose & route
40-100 mg PO daily
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Atomoxetine's effects?
- Read Off Label rates the evidence for Atomoxetine as Strong and the benefit magnitude as med, producing an overall grade of B (6.4/10). Full effect takes 4-8 weeks.
- What safety findings are reported for Atomoxetine?
- Atomoxetine has a med risk profile in the database. Med (hepatotoxicity warning, cardiovascular effects, suicidal ideation in youth) Legal status: Rx.
- What doses or routes are reported for Atomoxetine?
- 40-100 mg PO daily This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Atomoxetine work?
- Selective norepinephrine reuptake inhibitor; also increases PFC dopamine (NET clears DA in frontal cortex); non-stimulant; no abuse potential
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.